As per the official statement of the Sassoon General Hospital, currently, volunteer registration is going on for the trials.
Experts say a sustained behavioural change is required at least till there is a safe and effective vaccine.
AstraZeneca, the giant drug maker had put a stop on trials after a participant was discovered sick with transverse myelitis. This condition resulted in the inflammation of parts of the spinal cord
According to Russian researchers, Sputnik V is a human adenoviral vector vaccine which fights against coronavirus disease.
Dr Paul also informed the meeting about the progress made by the National Expert Group on Vaccine Administration for COVID-19.
Meanwhile, India's COVID-19 count crossed 33 lakh-mark with 75,760 fresh cases and 1,023 deaths, in the last 24 hours, the Ministry of Health and Family Welfare (MoHFW) said.
Dr Lalwani said phase two and three of trial is expected to end within three months and after that a detailed report with all the data of the trial phase will be sent to the government.
Ghaziabad (Uttar Pradesh) : Union Health Minister Dr Harsh Vardhan asserted that India’s first COVID-19 vaccine could be available by...
"We look to Indian drug producers to co-partner as we believe India is capable of producing Gamaleya Institute vaccine," said CEO of the Russian Direct Investment Fund (RDIF).
Earlier in August, the Russian Health Ministry registered the world's first COVID-19 vaccine, named Sputnik V developed by the Gamaleya Research Institute of Epidemiology and Microbiology. (ANI/Sputnik)